药物开发 药物开发
1Certara Predictive Technologies, Berwyn, PA, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
计算模型表明,减少病理性对阿尔茨海默氏症患者的好处更多的是早期阶段,并且取决于粉样蛋白水平. APOE基因型也影响了tau的降低效率,突出了药物开发的复杂相互作用.
科学领域:
- 计算神经科学是一种计算神经科学.
- 神经退行性疾病建模神经退行性疾病建模
- 药理动力学是什么 药理动力学
背景情况:
- 阿尔茨海默氏病 (AD) 治疗正在转向组合疗法,包括粉样蛋白和陶剂.
- 在优化治疗药物的时间,剂量和相互作用方面存在挑战.
- 还考虑了针对神经递质通路的小分子.
研究的目的:
- 模拟阿尔茨海默病中粉样蛋白和蛋白病理之间的复杂相互作用.
- 研究这些病理和APOE基因型对认知结果的影响.
- 为发展阿尔茨海默病的组合疗法提供信息.
主要方法:
- 利用皮层微电路的计算神经科学模型.
- 校准模型以ADAS-Cog分数进行校准.
- 粉样单/寡和错误折叠的对神经元通道和导电性的实施效应.
主要成果:
- 模型结果揭示了疾病状态,粉样蛋白和病理之间的复杂相互作用.
- 病理性tau的减少在AD中产生了比MCI更大的认知改善,但MCI的益处更大于较高的基线粉样蛋白.
- APOE基因型会影响tau的降低效率,特别是在不同的粉样蛋白负载水平下.
结论:
- 模拟表明疾病状态,粉样蛋白/蛋白负担和APOE基因型之间的复杂相互作用影响了临床结果.
- 忽视这些相互作用可能会降低治疗药物的临床疗效.
- 该模型可以指导阿尔茨海默病中粉样蛋白和酸剂的组合治疗策略.
更多相关视频
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
3.3K
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
451
相关概念视频
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation
279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
